CorMedix Inc.·4

Dec 16, 4:15 PM ET

Zelnick Kaufman Beth 4

4 · CorMedix Inc. · Filed Dec 16, 2024

Insider Transaction Report

Form 4
Period: 2024-12-12
Zelnick Kaufman Beth
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-12-12+12,50062,500 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-1212,50037,500 total
    Common Stock (12,500 underlying)
  • Tax Payment

    Common Stock

    2024-12-12$8.77/sh6,044$53,00656,456 total
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary